| 上证指数 深证成指 | 北证50 | | --- | --- | | 3965.28 13537.10 1456.45 | | | +1.60 +0.04% -66.80 -0.49% -6.59 -0.45% | | | 科创50 创业板指 | 万得全A | | 1346.32 3222.61 | 6413.01 | | +0.49 +0.04% -21.26 -0.66% -18.53 -0.29% | | | 沪深300 中证500 中证A500 | | | 4639.37 1 7430.61 5640.76 | | | -17.87 -0.38% -28.22 -0.38% -27.06 -0.48% | | | 中证1000 中证2000 中证红利 | | | 7594.16 3205.93 | 5501.74 | | -11.37 -0.15% -0.58 -0.02% -12.01 -0.22% | | | 行业板块 它 | | | 涨幅榜 资金净流入 | 5日涨幅榜 | | 化纤行业 林木 | 石油天然气 | | +3.93% +3.64% | +2.51% | | 燃气 多元金融 | 发 ...

12月29日，A股三大指数早盘冲高回落，午后震荡走低，截止收盘，沪指涨0.04%报3965.28点，连续九 日走高，深成指跌0.49%报13537.1点，创业板指跌0.66%报3222.61点，科创50指数涨0.04%报1346.32 点；沪深两市成交额2.14万亿，全市场超3300只个股下跌。 脑机接口概念表现活跃，海格通信、喜临门等涨停，翔宇医疗、麦澜德、三博脑科、创新医疗等跟涨。 消息面上，12月28日，第五届脑科学前沿与产业大会暨2025深圳脑机接口博览会启幕，"粤港澳大湾区 脑科学与中枢神经疾病AI创新联盟"正式启动。 盘面上，机器人概念午后反复活跃，上纬新材、步科股份20cm涨停创历史新高，五洲新春、模塑科技 等多股涨停。商业航天概念延续强势，神剑股份8连板，金风科技、雷科防务等十余股涨停。碳纤维概 念表现活跃，吉林化纤、和顺科技双双涨停；锂矿概念下挫，欣旺达跌逾11%；医药商业板块走弱，漱 玉平民跌超18%；氟化工板块回调，漱玉平民跌逾8%；电池概念午后震荡下挫，华盛锂电跌超7%；电 力板块持续走弱，国电电力跌近8%。 热点板块 商业航天概念延续强势 商业航天概念延续强势，10余只成分股涨停，神 ...

Market Overview - The A-share market indices collectively weakened today, with the Shanghai Composite Index closing slightly up by 0.04% at 3965 points, marking a nine-day winning streak [1] - The Shenzhen Component Index fell by 0.49%, and the ChiNext Index decreased by 0.66% [1] - Total market turnover was 2.16 trillion yuan, a decrease of 234 billion yuan compared to the previous trading day, with over 3300 stocks declining [1] Sector Performance - The carbon fiber and chemical fiber sectors saw gains, with Shenjian Co. and Huading Co. hitting the daily limit [1] - The commercial aerospace concept continued to perform strongly, with China Satellite also reaching the daily limit [1] - The robotics sector was active, with Wuzhou New Spring hitting the daily limit [1] - The PEEK materials sector rose, with Hengbo Co. increasing by 20% [1] - Other sectors with notable gains included digital currency, oil, diversified finance, and wind power equipment [1] - Conversely, the lithium mining concept declined, with XWANDA dropping over 11% [1] - The pharmaceutical commercial sector weakened, with Shuyapingmin falling over 18% [1] - The fluorochemical sector also retreated, with Shuyapingmin down over 8% [1] - Other sectors with significant declines included dairy, batteries, and electricity [1] Top Gainers and Fund Inflows - The chemical fiber industry led the gainers with an increase of 3.93% [2] - The diversified finance sector followed with a rise of 2.20% [2] - The top sectors for net capital inflow included forestry and gas, with respective increases of 3.64% and 1.57% [2]

（文章来源：每日经济新闻） 每经AI快讯，12月29日，医药商业股持续下挫，漱玉平民跌超18%，人民同泰、达嘉维康、英特集团、 药易购均跌逾5%，华人健康、重药控股、开开实业等跟跌。 ...

| 序号 | 板块 | 涨跌幅(%)▼ | 总成交量（万手）▼ | 总成交额（亿元） ▼ | 净流入(亿元) ▼ | 上涨家数 | 下跌家 | | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 化学纤维 | 2.58 | 784.92 | 62.96 | -3.41 | 22 | 6 | | 2 | 元件 | 1.77 | 959.26 | 412.36 | 34.68 | 48 | 12 | | 3 | 多元金融 | 1.63 | 1016.16 | 96.15 | -0.57 | 19 | 7 | | ব | 塑料制品 | 1.60 | 1117.74 | 186.76 | 0.91 | 43 | 30 | | 5 | 串等属 | 1.59 | 603.00 | 92.17 | 6.21 | 8 | ന | | ଚ | 石油加工贸易 | 1.39 | 686.00 | 61.86 | 10.80 | 19 | ထ | | 7 | 风电设备 | 1.09 | 577.12 | 110.56 | -0.36 | 21 | ਰੇ | | 8 | 电机 ...

Market Performance - The A-share market showed mixed performance with the Shanghai Composite Index rising by 0.31% to 3975.92 points, while the Shenzhen Component Index increased by 0.03% and the ChiNext Index fell by 0.32% [1] - The North China 50 Index saw a slight increase of 0.11% [1] Trading Volume - The total trading volume in the Shanghai and Shenzhen markets reached 1.4078 trillion yuan, which is a decrease of 57.8 billion yuan compared to the previous day [1] - Over 3400 stocks experienced declines during the trading session [1] Sector Performance - The PEEK materials, brain-computer interface, and precious metals sectors showed significant gains [1] - Conversely, the pharmaceutical commercial, dairy, and battery sectors experienced declines [1]

Market Performance - The three major A-share indices showed mixed results, with the Shanghai Composite Index rising by 0.31% to close at 3975.92 points [1] - The Shenzhen Component Index increased by 0.03%, while the ChiNext Index fell by 0.32% [1] - The North China 50 Index saw a slight increase of 0.11% [1] Trading Volume - The total trading volume in the Shanghai and Shenzhen markets reached 1.4078 trillion yuan, which is a decrease of 57.8 billion yuan compared to the previous day [1] - Over 3,400 stocks experienced declines during the trading session [1] Sector Performance - The PEEK materials, brain-computer interface, and precious metals sectors showed significant gains [1] - Conversely, the pharmaceutical commercial, dairy, and battery sectors experienced declines [1]

A股开盘，三大指数涨跌不一，沪指涨0.02%报3964.65点，深证成指平开，创业板指跌0.19%。盘面 上，国际银价、铜价屡创新高，贵金属及有色金属板块涨幅延续，造纸、医药商业板块低开。 ...

Group 1 - The pharmaceutical commercial sector experienced a decline at the beginning of trading, with notable drops in stock prices [1] - Shuyupingmin saw a decrease of over 15%, while Renmintongtai fell by more than 7% [1] - Other companies such as Huaren Health, Dajia Weikang, and Ruikang Pharmaceutical also followed the downward trend [1]

Core Viewpoint - The investigation of Gao Yuwen, former chairman of China Medical Health Industry Co., Ltd., highlights ongoing anti-corruption efforts within the company, which has seen multiple executives investigated for serious violations in recent years [1][2]. Group 1: Investigation and Leadership Changes - Gao Yuwen is under investigation for serious violations and is being reviewed by the Central Commission for Discipline Inspection and the Tianjin Municipal Supervisory Committee [1]. - Since 2024, at least 11 executives or former executives from China Medical have been investigated for misconduct [2]. - Li Xin, former assistant general manager, was also investigated for serious violations and had overlapping work periods with Gao Yuwen [2]. Group 2: Company Structure and Operations - China Medical, established in 1983, is the only pharmaceutical and medical device production and operation platform under the General Technology Group [1]. - The company operates in four main sectors: international trade, pharmaceutical commerce, medical devices, and pharmaceutical industry [2]. Group 3: Financial Performance - In 2024, the company reported a revenue of 34.148 billion yuan, a year-on-year decrease of 12.04%, and a net profit of 535 million yuan, down 48.91% [3]. - In the first half of 2025, revenue was 17.076 billion yuan, a decline of 6.71%, with a net profit of 294 million yuan, down 16.19% [3]. - For the first three quarters of 2025, the net profit attributable to shareholders was 477 million yuan, a year-on-year decrease of 4.64% [4].